A1,
A2,
B,
C1,
C2,
D,
E,
F,
G-H,
I-K,
L,
M,
N,
O,
P1,
P2,
Q-R,
S,
T,
U-V,
W-Z
Certiva Patient, Information, Instructions - Certiva
Certiva Patient, Information, Instructions - Certiva
PATIENT INFORMATION
INFORMATION FOR VACCINE RECIPIENTS AND PARENTS
Parents or guardians of infants and children to be vaccinated should
be fully informed of the benefits and risks of vaccination
with CertivaTM and the importance of completing the immunization
series, unless contraindicated.
The physician should
inform the parents or guardians about the potential for adverse
reactions that have been temporally associated with CertivaTM
and other pertussis
vaccine administrations.
The parents or guardians of infants and children with family
history of convulsions
or other central nervous system
disorders should be advised of the potential
increased risk of seizures following DTP vaccinations.
Prior to each immunization,
the parent or guardian
should be provided with the Vaccine Information Materials (VIMs),
as required by the National Childhood Vaccine Injury Act of 1986.
26 Parents or guardians should be instructed to report
any severe or unusual reactions to their health-care provider.
The U. S. Department of Health and Human Services has established
a Vaccine Adverse Event Reporting System (VAERS) to accept all reports
of suspected adverse events after the administration
of any vaccine, including,
but not limited to, the reporting of events required by the National
Childhood Vaccine Injury Act of 1986. 29, 30 The toll-free
number for VAERS forms
and information is 1-800-822-7967.
top
